Background: Long-staying medical inpatients carry a significant burden of acute and chronic illness. Prediction of their in-hospital and longer-term mortality risk is important. Aim: The aim of this study was to determine to what extent creatinine variability predicts in-hospital and 1-year mortality in inpatients. Design: Retrospective cohort analysis. Methods: Patients were included if aged 18 years or older and if admitted for 7 days or longer. The main outcome variables were mortality in hospital and after discharge. Results: Increasing age, the presence of heart failure and a reduced estimated glomerular filtration rate (eGFR) on admission (<60 ml/min/1.73 m
Introduction
Patients admitted to a hospital's medical services for over 1 week often have complex co-morbidities such as heart and kidney failure rather than simple single system disease. 1, 2 These patients are usually both acutely and chronically unwell with 5% dying during their admission to hospital and another 20% dying within a year of discharge. 3 Within the one admission, serum creatinine fluctuates by over 20% in more than half of these longstay medical inpatients. 4 Since the clearance of creatinine from the plasma reflects renal function, this fluctuation may represent acute changes in the patient's glomerular filtration rate (GFR). Rapid changes in the GFR often reflect acute kidney injury (AKI), which itself increases patient mortality risk both during hospital admission and in the first year following discharge from hospital. [5] [6] [7] However, fluctuation in serum creatinine may also reflect laboratory assay variability (usually up to 9 mmol/l), [8] [9] [10] and dietary and metabolic variability. Dietary protein can affect GFR estimates by up to 20 ml/min/1.73 m 2 8,11-13 and the body's creatinine generation rate (CGR) ranges over 10-fold (1.7-22.4 mg/kg/day) particularly in the presence of acute illness. 14, 15 Whether creatinine variation is due to AKI or not, it is important to identify patients at risk of early or late mortality. Early identification will not only offer an opportunity to optimize care and reduce mortality in the short term but could also result in the implementation of focused strategies to reduce the mortality of this vulnerable population after their discharge from hospital. The consequences of creatinine variation are poorly understood, although recent work in outpatients with chronic kidney disease (CKD) suggests increased creatinine variability over 3 years of outpatient monitoring is associated with a greater risk of mortality. 16, 17 The aim of this study was to identify, in a medical inpatient population, any association between mortality and short-term creatinine change. We also sought to determine the creatinine variation threshold above which mortality risk rises; distinguishing whether death occurs in hospital or within a year after discharge. A simple measure of creatinine variability was chosen for analysis, and the importance of patient age and of cardiac and renal failure to the relation of mortality to creatinine change was also examined.
Subjects and methods
Medical patients aged 18 years and older, admitted to Flinders Medical Centre between 1 January 2005 and 31 December 2012, were included in this retrospective study. Patients were included if they were an unscheduled admission for 7 days or longer with at least two creatinine test results recorded. Elective patients were excluded from this study as were those who were admitted to the intensive care unit or those who were principally admitted to hospital for palliative care. If a patient was admitted to hospital more than once during the study period, only the first admission was included. In this study, plasma creatinine was measured using the Hitachi Modular P800 Chemistry autobioanalyzer using the modified Jaffe creatinine assay; the estimated GFR (eGFR) was estimated using the CKD Epidemiology Collaboration (CKD-EPI) study equation, which provided a more accurate estimation of GFR compared with the abbreviated Modification of Diet in Renal Disease equation. 18 This study was approved by Southern Adelaide Clinical Human Research Ethics Committee.
Outcome variables
The main outcome variables in this study were in-hospital mortality and 1-year mortality following discharge. One year mortality was calculated from the day of discharge and based on those patients who were discharged alive. Creatinine variability was measured as the maximal absolute change in creatinine during the entire hospitalization from the admission baseline measurement; the latter being measured within 24 h of admission.
To find the threshold for a critical change in mortality, we built logistic regression models for both in-hospital and 1-year mortality using absolute change in creatinine (grouped within 5 mmol/l) as a categorical variable and we made pairwise comparison in categories for group categories. For in-hospital mortality, the absolute change in creatinine was categorized as follows: 0-25 mmol/l, 25-50 mmol/l and 50 mmol/l and over. For 1-year mortality, the absolute change in creatinine was categorized as 0-10 mmol/l, 10-50 mmol/l and 50 mmol/l and over. Therefore, for further analysis, we categorized the absolute change in creatinine as 0-10 mmol/l, 10-25 mmol/l, 25-50 mmol/l and 50 mmol/l and over. Change in in-hospital mortality and mortality within 1 year for a rise or a fall in creatinine during admission was compared using a logistic regression model.
Statistical analysis
Data were analysed using Stata 13.1 (Statacorp, Texas). Data are presented as a percentage (%) with number (n) for categorical data unless otherwise stated. Patients' characteristics were compared between patients with and without heart failure using the Chi-squared test for categorical variables and Wilcoxon's rank sum test for continuous variables. A logistic regression model was used to examine the effect of creatinine variability on in-hospital and 1-year mortality, adjusted for age, sex, presence of heart failure (i.e. patients with ICD-10-CM diagnosis code, I50) and low baseline eGFR (baseline eGFR <60 ml/min/1.73 m 2 ). For creatinine variability, the linearity assumption was not satisfied, so we categorized the absolute change in creatinine by 5 mmol/l increments (i.e. 0 to <5 mmol/l, 5 mmol/l to <10 mmol/l). The linearity assumption for this new variable was checked for both in-hospital and 1-year mortality models, and it was used as a continuous variable to examine the effect of creatinine variability on in-hospital and 1-year mortalities. We also examined the effect of any interaction between the baseline eGFR and creatinine variability on both inhospital and 1-year mortalities. Statistical significance was defined as a P value of <0.05.
Results
Certain characteristics and outcomes of our patients are presented in Table 1 . Those with a lower eGFR on admission were older (P < 0.001), more likely to have heart failure (P < 0.001) and had a higher mortality in-hospital (P < 0.001) and in the year after discharge (P < 0.001). Serum creatinine fluctuated by over 20 mmol/l in 57.7% of all patients (Table 2) . Figure 1 presents the in-hospital mortality and mortality within 1 year after discharge as functions of the direction and degree of maximal creatinine change during the index admission of over 7 days. Compared to creatinine stability, a rise in creatinine during the hospital admission predicted a higher inhospital mortality risk than did an equivalent fall in creatinine (P < 0.001), whereas a fall in creatinine predicted a higher mortality risk within 1 year than an equivalent rise (P = 0.009). The probability of prolonged survival after discharge declined with the magnitude of the maximal absolute change in creatinine during the index admission (Figure 2) .
The threshold of creatinine change, above which the in hospital mortality rose significantly, was 25 mmol/l (P < 0.001). The creatinine change a The creatinine change for each case is the absolute value of the maximum deviation during the inpatient admission from the baseline value on the day of admission.
threshold above which the mortality within a year of discharge rose significantly was only 10 mmol/l (P < 0.001). A continuous and significant association existed between the extent of the creatinine change and in hospital mortality risk (P < 0.001), where every 5 mmol/l change in creatinine was associated with a 3% increase in in-hospital mortality. Mortality in the year after discharge also associated with the size of the creatinine change (P = 0.007), where every 5 mmol/l change in creatinine was associated with a 1% increase in 1-year mortality. Increasing age, the presence of heart failure and a reduced eGFR on admission (<60 ml/min/1.73 m 2 ) all associated with death risk (both in hospital and within a year of discharge) ( Table 3 ). The creatinine change affected mortality risk (in hospital and 1 year after discharge) independently of these other factors. The impact of low eGFR on in-hospital mortality was not significant when the model was adjusted for age and heart failure (if present).
Irrespective of the baseline (i.e. admission) eGFR, change in creatinine associated with both in-hospital (P < 0.001) and 1-year mortality (P = 0.007). The in-hospital mortality risk per unit of creatinine change increased at a higher rate if the patient had low baseline eGFR (<60 ml/min/ 1.73 m 2 ) (P < 0.001).
Discussion
The majority of this cohort of >6,000 inpatients experienced a change in serum creatinine of >20 mmol/l during their admission to hospital. Overall, in-hospital mortality and 1-year mortality rates within this population matched other similarly aged medical inpatient cohorts. 3 Creatinine changes within the one admission (decreases as well as increases) identified patients at-risk of dying either during the index admission or within a year after discharge. As the magnitude of the maximal creatinine change increased, irrespective of its direction, the chances of the patient surviving to discharge decreased. If patients survived to discharge, their chances of surviving another year also dropped in proportion to the extent of the maximal creatinine change during the index admission, again irrespective of its direction. Mortality was particularly high if the creatinine rose or fell over 50 mmol/l during the index admission; presumably reflecting the high short-and long-term mortality of patients with a history of AKI-even if GFR improves significantly after admission to hospital. 19, 20 One systematic review shows that even very small increases in serum creatinine levels, of the order of 10-24% (26-35 mmol/l) are associated with 2-fold risk of short-term death across a broad spectrum of clinical settings. Furthermore, greater elevations in serum creatinine levels of 25-49% (44-80 mmol/l) are associated with a 3-to 5-fold increase in risk of death. 21 It is unclear where the threshold lies for a clinically significant change in serum creatinine during a hospital admission. We believe there is clinical significance in a small change in creatinine that is barely beyond the combination of laboratory error margins and the variance due to factors involving patients' diet and CGR (changes of 10-25 mmol/l within a week). If the serum creatinine of an inpatient changes by an appreciable amount (25%), this change is usually ascribed to changes in GFR 17 and in-hospital mortality risk is increased. The cause of a smaller change in creatinine may be a smaller change in GFR due to, for example, impaired autoregulation of glomerular pressure, 22 but such creatinine changes may also reflect something other than glomerular filtration. For example, CGR changes consequent to altered muscle mass, acute illness, humorally mediated muscle production of creatine (subsequently metabolized to creatinine) or poor nutrition may contribute to any observed change in serum creatinine. 17, 23 Failure to appreciate variation in CGR may lead to erroneous conclusions regarding the severity of AKI or CKD and result in distorted predictions regarding patient outcomes based on AKI severity. One study has shown a marked reduction in CGR among a cohort of critically ill patients and CGR performed better as a predictor of in-hospital mortality than a variety of other factors.
14 Our study was not designed to identify the reasons behind a change in serum creatinine. Measurements of CGR in patients with AKI are difficult because these patients are often not in a steady state, thus making urinary collections for creatinine excretion virtually uninterpretable.
14 Ideally, studies investigating CGR require patients to be on dialysis in order to overcome the challenges imposed in acute illness where AKI can confound analysis.
While heart failure, older age and a reduced eGFR on admission all increase patient mortality risk, a creatinine change in either direction during the index admission was also associated with an increased mortality risk, independent of these other factors. Most patients with heart failure exhibit renal dysfunction, the cardiorenal syndrome, 5, 24 which is strongly associated with mortality. [25] [26] [27] An interdependent relationship between the heart and the kidneys has led to the concept of this syndrome where neurohormonal activation is believed to occur. Elevated norepinephrine, renin and aldosterone levels are a feature of this syndrome and all associate with mortality and independently associate with abnormal cardiac and renal function. 28 Whatever the basis of an interaction between cardiac and renal failure on early and late mortality of in-patients, the co-existence of renal and heart failure in our population increased short-and long-term mortality risk independently of age and creatinine changes during the index admission.
Mortality risk associates with the creatinine variability observed in outpatients with chronic renal impairment over a period of months or years. 16, 17 We have extended this observation to involve hospital inpatients; reporting that sub-acute changes in creatinine (in either direction) also predict both short-and long-term mortality risk. Our measure of creatinine variability is easily calculated at the bedside on review of each patient's biochemistry results. We propose that patients, whose admission exceeds 7 days, with a creatinine rise or fall of over 10 mmol/l, are at a higher risk of death after discharge than those with a more stable creatinine during admission. These patients, once identified, therefore merit more focused nutritional assessment, cardiovascular risk factor management or advance care planning where appropriate. Their death risk may not be attributable solely to changes in GFR.
This study has some limitations that should be considered. A sicker patient is more likely to have a prolonged hospitalization and thus have more blood tests including assessments of renal function, increasing the probability of creatinine variability. The retrospective cross-sectional design of this study precludes inferences about causality but adds useful knowledge about the association of creatinine variability and mortality. This study involved only a single hospital which limits the generalization of these findings to admissions to other hospitals.
In conclusion, we propose greater attention be paid to the absolute change in creatinine in each medical patient admitted to hospital for over a week. If the creatinine change exceeds 10 mmol/l in either direction, these patients' long-term mortality risk is significantly elevated. A small creatinine change, close to that attributable to laboratory error and metabolic variation, carries long-term clinical significance.
